Related Experiment Videos
Increased MAPK expression and activity in primary human hepatocellular carcinoma
C M Schmidt1, I H McKillop, P A Cahill
1Department of Surgery, Georgetown University Medical Center, Washington, DC 20007, USA.
Biochemical and Biophysical Research Communications
|July 9, 1997
Summary
Mitogen-activated protein kinase (MAPK) shows increased expression and activity in human hepatocellular carcinoma (HCC). This MAPK pathway overexpression may be crucial for the development and progression of liver cancer.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Hepatocellular carcinoma (HCC) is a major global health concern.
- The mitogen-activated protein kinase (MAPK) pathway regulates critical cellular processes like growth and differentiation.
Purpose of the Study:
- To investigate the expression and functional activity of MAPK pathway components in human HCC.
- To determine if MAPK pathway alterations are associated with HCC development.
Main Methods:
- Western blotting was used to quantify MAPK pathway intermediates (Erk-1, Erk-2, Mek-1, Mek-2) in HCC tumors and adjacent normal liver tissues.
- Functional activity of Erk-2 was assessed by myelin basic protein (MBP) phosphorylation assays.
Main Results:
- Significantly elevated expression of Erk-1, Erk-2, Mek-1, and Mek-2 was observed in HCC tissues compared to normal tissues.
- Functional activity of Erk-2 was markedly increased in both membrane and cytosolic fractions of HCC specimens.
- Specific increases in Erk-2 activity were 321% in membranes and 597% in cytosol relative to normal tissue.
Conclusions:
- This study provides the first evidence of increased MAPK expression and activity in human HCC.
- Overexpression and enhanced activity of the MAPK pathway are implicated in the formation and maintenance of hepatocellular carcinoma.
- Targeting the MAPK pathway may offer therapeutic strategies for HCC.